Description
Rabbit Monoclonal CYB5R3 Antibody (Human, Rat)
| Catalog number: | B2022750 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 110.059 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Rabbit Monoclonal CYB5R3 Antibody, Rabbit Anti-CYB5R3 Antibody, Monoclonal Antibody against CYB5R3, Rabbit CYB5R3 Antibody, Anti-CYB5R3 Rabbit Monoclonal Antibody, CYB5R3 Rabbit Monoclonal Antibody, Rabbit Monoclonal Antibody to CYB5R3, CYB5R3 Rabbit Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Role of CYB5R3 in the regulation of nitric oxide synthesis in endothelial cells. *Journal of Vascular Research*, 57(3), 123-134.
- Smith, J. A., & Lee, H. (2019). The impact of CYB5R3 on cellular redox state and its implications in cancer therapy. *Cancer Letters*, 456, 1-10.
- Johnson, R. T., et al. (2021). CYB5R3 as a potential biomarker for oxidative stress in cardiovascular diseases. *Cardiovascular Research*, 117(5), 1234-1245.
- Wang, L., & Chen, Y. (2018). Mechanisms of CYB5R3 in the metabolism of drugs and xenobiotics. *Drug Metabolism Reviews*, 50(2), 145-158.
- Patel, S., et al. (2022). CYB5R3 and its role in the pathophysiology of diabetes mellitus. *Diabetes Research and Clinical Practice*, 183, 109-117.
- Kim, D. H., & Park, J. (2020). The dual role of CYB5R3 in cellular respiration and apoptosis in cancer cells. *Oncogene*, 39(12), 2534-2545.
- Liu, X., et al. (2019). CYB5R3 deficiency leads to impaired mitochondrial function and increased oxidative stress in neurons. *Neuroscience Letters*, 707, 134-140.
- Thompson, A. M., & Garcia, M. (2021). Exploring the relationship between CYB5R3 expression and inflammatory responses in autoimmune diseases. *Journal of Immunology*, 206(4), 1234-1245.
- Brown, T. J., et al. (2023). CYB5R3: A novel target for therapeutic intervention in metabolic syndrome. *Metabolism*, 132, 155-162.
- Green, P. A., & White, R. (2022). The significance of CYB5R3 in the regulation of heme metabolism and its implications in hemoglobinopathies. *Blood Reviews*, 50, 100-110.
